tiprankstipranks
FSD Pharma (TSE:HUGE)
CNQX:HUGE
Canadian Market

FSD Pharma Stock Analysis & Ratings

TSE:HUGE Stock Chart & Stats

Day’s RangeC$1.2 - C$1.21
52-Week RangeC$1.01 - C$2.66
Previous CloseC$1.22
Volume5.13K
Average Volume (3M)83.52K
Market CapC$46.19M
P/E Ratio-0.9
Beta0.81
Next EarningsAug 12, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score1
EPS (TTM)-1.32


FSD Pharma News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

TSE:HUGE FAQ

What was FSD Pharma’s price range in the past 12 months?
FSD Pharma lowest stock price was C$1.01 and its highest was C$2.66 in the past 12 months.
    What is FSD Pharma’s market cap?
    FSD Pharma’s market cap is C$46.19M.
      What is FSD Pharma’s price target?
      Currently, no data Available
      What do analysts say about FSD Pharma?
      Not enough analysts have published a price target to provide an average price target.
      When is FSD Pharma’s upcoming earnings report date?
      FSD Pharma’s upcoming earnings report date is Aug 12, 2022 which is in 85 days.
        How were FSD Pharma’s earnings last quarter?
        Currently, no data Available
        Is FSD Pharma overvalued?
        According to Wall Street analysts FSD Pharma’s price is currently Overvalued.
          Does FSD Pharma pay dividends?
          FSD Pharma does not currently pay dividends.
          What is FSD Pharma’s EPS estimate?
          FSD Pharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does FSD Pharma have?
          FSD Pharma has 38,490,000 shares outstanding.
            What happened to FSD Pharma’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of FSD Pharma?
            Currently, no hedge funds are holding shares in TSE:HUGE

            ---

            FSD Pharma Stock Analysis

            Smart Score
            1
            Underperform
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            Price Target
            No data currently available
            The FSD Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            FSD Pharma

            FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.

            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Sonoma Pharmaceuticals
            WiSA Technologies, Inc.
            Cinedigm
            Immuron
            Phio Pharmaceuticals

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis